Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.

João EstarrejaPriscila Mendes Carina Silva Pedro Camacho Vanessa Mateus

Published in: Pharmaceuticals (Basel, Switzerland) (2024)

Clinical evidence demonstrates that bevacizumab has efficacy and safety profiles comparable with ranibizumab; however, it is relatively more efficient.

Keyphrases

age related macular degeneration
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
metastatic colorectal cancer
peritoneal dialysis
patient reported
optical coherence tomography